IA
CPRX

IFP Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

IFP Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.1K Buy
2,963
+963
+48% +$28.4K ﹤0.01% 2029
2026
Q1 		$49.5K Buy
2,000
+1,052
+111% +$25.1K ﹤0.01% 2251
2025
Q4 		$22.1K Buy
948
+945
+31,500% +$21.1K ﹤0.01% 2682
2025
Q3 		$59 Sell
3
-101
-97% -$2.08K ﹤0.01% 4631
2025
Q2 		$2.26K Buy
104
+81
+352% +$1.91K ﹤0.01% 3842
2025
Q1 		$558 Hold
23
– – ﹤0.01% 3438
2024
Q4 		$480 Buy
+23
New +$494 ﹤0.01% 3427
2023
Q3 		– Sell
-670
Closed -$9K – 3344
2023
Q2 		$9K Buy
670
+170
+34% +$2.45K ﹤0.01% 2336
2023
Q1 		$1.81K Sell
500
-1,523
-75% -$25.1K ﹤0.01% 2927
2022
Q4 		$12K Sell
2,023
-376
-16% -$5.79K ﹤0.01% 3253
2022
Q3 		$9K Hold
2,399
– – ﹤0.01% 3698
2022
Q2 		$9K Hold
2,399
– – ﹤0.01% 3454
2022
Q1 		$9K Buy
+2,399
New +$17K ﹤0.01% 3454
2019
Q4 		– Sell
-1,324
Closed -$6.19K – 2874
2019
Q3 		$7K Buy
+1,324
New +$7.05K ﹤0.01% 2209
2017
Q4 		– Sell
-1,000
Closed -$3K – 3841
2017
Q3 		$3K Hold
1,000
– – ﹤0.01% 3597
2017
Q2 		$3K Hold
1,000
– – ﹤0.01% 3591
2017
Q1 		$2K Hold
1,000
– – ﹤0.01% 3632
2016
Q4 		$1K Hold
1,000
– – ﹤0.01% 3759
2016
Q3 		$1K Hold
1,000
– – ﹤0.01% 3699
2016
Q2 		$1K Buy
+1,000
New +$806 ﹤0.01% 3591

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFP Advisors's CPRX Position: Q2 2026 in Review

IFP Advisors increased its Catalyst Pharmaceutical (CPRX) stake by 48% in Q2 2026, buying an estimated $28.4K and bringing the position to 2,963 shares worth $93.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

IFP Advisors first reported a position in CPRX in Q2 2016 and has held it in 20 quarters since. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • IFP Advisors held 2,963 shares of Catalyst Pharmaceutical worth $93.1K as of Q2 2026.
  • IFP Advisors bought 963 Catalyst Pharmaceutical shares in Q2 2026, an estimated $28.4K.
  • Catalyst Pharmaceutical made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2029 holding.
  • IFP Advisors first reported a position in Catalyst Pharmaceutical in Q2 2016 and has held it in 20 quarters since.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.